指标,指标类型,分层,治疗组例数,治疗组变化均值,治疗组变化SD,对照组例数,对照组变化均值,对照组变化SD,组间差异,t检验P值,Mann-Whitney P值,Cohen's d,统计学差异,临床意义
ALT,主要,全人群,140,0.28428571428571425,11.523240647738541,141,-0.475177304964539,10.171796835426647,0.7594630192502533,0.5586632373026991,0.9894450019764364,0.06987715865143002,否,对照组更优或无差异
AST,主要,全人群,140,0.6199285714285714,8.466463889146883,141,0.04964539007092199,6.442411084961849,0.5702831813576494,0.5259395463830706,0.9788731396689917,0.07580709177015652,否,对照组更优或无差异
GGT,次要,全人群,140,2.914285714285714,23.02875453552251,141,0.0851063829787234,20.66829503013946,2.8291793313069906,0.2795189671070069,0.10026721367789755,0.12930211831078647,否,对照组更优或无差异
ALP,次要,全人群,142,-1.6143911439114391,15.7654362029941,141,-1.5815602836879432,22.24093909514254,-0.032830860223495906,0.9885884872160218,0.9530646088147187,-0.0017031071399054637,否,治疗组更优
白蛋白,次要,全人群,143,-0.07748251748251753,2.354653608845674,141,1.495035460992908,5.962505780064699,-1.5725179784754255,0.003997019530928648,0.1840952374000615,-0.34690577857307175,否,对照组更优或无差异
胆红素,次要,全人群,140,0.7697857142857144,5.506750006782995,141,1.839716312056738,8.851552563030351,-1.0699305977710236,0.22463716366109396,0.33543840546922865,-0.14514671888775513,否,治疗组更优
